Home LiteratureArticle Details
PMID: 17533199 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.

Hypertension (Dallas, Tex. : 1979) ·Vol. 50 ·No. 2 ·2007-08-00 ·Pages 384-91

Wei Y, Whaley-Connell AT, Chen K, Habibi J, Uptergrove GM, Clark SE, Stump CS, Ferrario CM, Sowers JR

Abstract

Reduced insulin sensitivity is characteristic of various pathological conditions such as type 2 diabetes mellitus and hypertension. Angiotensin II, acting through its angiotensin type 1 receptor, inhibits the actions of insulin in the vasculature which may lead to deleterious effects such as vascular inflammation, remodeling, endothelial dysfunction, and insulin resistance. In contrast, insulin normally exerts vasodilatory, antiinflammatory, and prosurvival actions. To explore the impact of angiotensin II on insulin signaling, NADPH oxidase-derived reactive oxygen species formation, vascular inflammation, apoptosis, and remodeling, we used transgenic TG(mRen2)27 (Ren2) rats, which harbor the mouse renin transgene and exhibits elevated tissue angiotensin II levels. Compared with Sprague-Dawley controls, Ren2 aortas exhibited greater NADPH oxidase activity, reactive oxygen species levels, C-reactive protein, tumor necrosis factor-alpha expression, apoptosis, and wall thickness, which were significantly attenuated by in vivo treatment with angiotensin type 1 receptor blockade (valsartan) or the superoxide dismutase/catalase mimetic (tempol). There was substantially diminished Akt and endothelial NO synthase activation in Ren2 aortas in response to in vivo insulin stimulation, and this was significantly improved by in vivo treatment with valsartan or tempol. In vivo treatment with valsartan, but not tempol, significantly reduced blood pressure in Ren2 rats. Further, there was reduced insulin induced Akt activation and increased tumor necrosis factor-alpha levels in vascular smooth muscle cells from Ren2 and Sprague-Dawley rats treated with angiotensin II, abnormalities that were abrogated by angiotensin type 1 receptor blockade with valsartan or antioxidant N-acetylcysteine. Collectively, these data suggest that increased angiotensin type 1 receptor/NADPH oxidase activation/reactive oxygen species contribute to vascular insulin resistance, endothelial dysfunction, apoptosis, and inflammation.

MeSH Terms
Animals Animals, Genetically Modified Apoptosis/drug effects Blood Pressure/drug effects,physiology Blotting, Western C-Reactive Protein/metabolism Cells, Cultured Disease Models, Animal Enzyme-Linked Immunosorbent Assay Fluorescent Antibody Technique Insulin Resistance/physiology Male Muscle, Smooth, Vascular/drug effects,physiology NADPH Oxidases/drug effects,metabolism Probability Random Allocation Rats Rats, Sprague-Dawley Reactive Oxygen Species/metabolism Sensitivity and Specificity Superoxide Dismutase/pharmacology Tetrazoles/pharmacology Valine/analogs & derivatives,pharmacology Valsartan Vasculitis/drug therapy,enzymology
Chemicals
Reactive Oxygen Species Tetrazoles Valsartan C-Reactive Protein Superoxide Dismutase NADPH Oxidases Valine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Wei Yongzhong
University of Missouri-Columbia, Harry S. Truman VA Medical Center, Columbia, MO, USA.
Whaley-Connell Adam T
Chen Kemin
Habibi Javad
Uptergrove Grace M-E
Clark Suzanne E
Stump Craig S
Ferrario Carlos M
Sowers James R
Article Info
Journal
Hypertension (Dallas, Tex. : 1979)
Abbr.
Hypertension
ISSN
1524-4563
Published
2007-08-00
Epub
2007-00-28
Pages
384-91
Language
English
Region
United States
NLM ID
7906255
Subset
IM
Grants
NHLBI NIH HHS · P01 HL-51952 · United States
NHLBI NIH HHS · R01-HL073101-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]